GeneDx Holdings Corp. Increase (Decrease) in Accounts Receivable
GeneDx Holdings Corp. (WGS) reported Increase (Decrease) in Accounts Receivable of $9.24 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-03
- GeneDx Holdings Corp. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $6.68M, a 401.65% increase year-over-year.
- GeneDx Holdings Corp. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was $2.56M, a 70.11% decline year-over-year.
- GeneDx Holdings Corp. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was $13.43M.
- GeneDx Holdings Corp. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $12.91M, a 3.51% increase year-over-year.
- GeneDx Holdings Corp. increase (decrease) in accounts receivable for fiscal 2025 was $36.23M, a 599.44% increase from fiscal 2024.
- GeneDx Holdings Corp. increase (decrease) in accounts receivable for fiscal 2024 was $5.18M.
- GeneDx Holdings Corp. increase (decrease) in accounts receivable for fiscal 2023 was -$10.53M.
- GeneDx Holdings Corp. increase (decrease) in accounts receivable for fiscal 2022 was -$5.53M.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 6 month as first filed | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month | Increase (Decrease) in Accounts Receivable 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $9.24M 10-Q · filed 2026-08-03 | $22.67M derived: sum of 3 quarters · filed 2026-08-03 | $35.58M derived: sum of 4 quarters · filed 2026-08-03 | ||
| 2026-03-31 | $2.56M 10-Q · filed 2026-05-04 | $15.99M derived: sum of 2 quarters · filed 2026-05-04 | $28.90M derived: sum of 3 quarters · filed 2026-05-04 | $30.23M derived: sum of 4 quarters · filed 2026-08-03 | ||
| 2025-12-31 | $13.43M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $26.34M derived: sum of 2 quarters · filed 2026-02-23 | $27.67M derived: sum of 3 quarters · filed 2026-08-03 | $36.23M 10-K · filed 2026-02-23 | ||
| 2025-09-30 | $12.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $14.24M derived: sum of 2 quarters · filed 2026-08-03 | $22.80M 10-Q · filed 2025-10-28 | $22.13M derived: sum of 4 quarters · filed 2026-08-03 | ||
| 2025-06-30 | $1.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $9.89M 10-Q · filed 2026-08-03 | $9.22M derived: sum of 3 quarters · filed 2026-08-03 | $21.69M derived: sum of 4 quarters · filed 2026-08-03 | ||
| 2025-03-31 | $8.56M 10-Q · filed 2026-05-04 | $7.89M derived: sum of 2 quarters · filed 2026-05-04 | $20.36M derived: sum of 3 quarters · filed 2026-05-04 | $17.96M derived: sum of 4 quarters · filed 2026-05-04 | ||
| 2024-12-31 | -$670.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $11.80M derived: sum of 2 quarters · filed 2026-02-23 | $9.40M derived: sum of 3 quarters · filed 2026-02-23 | $5.18M 10-K · filed 2026-02-23 | $5.42M 10-K · filed 2025-02-20 | |
| 2024-09-30 | $12.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $10.07M derived: sum of 2 quarters · filed 2025-10-28 | $5.85M 10-Q · filed 2025-10-28 | $6.05M derived: sum of 4 quarters · filed 2026-02-23 | ||
| 2024-06-30 | -$2.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | -$6.62M 10-Q · filed 2025-07-29 | -$6.87M 10-Q · filed 2024-07-30 | -$6.42M derived: sum of 3 quarters · filed 2026-02-23 | -$6.97M derived: sum of 4 quarters · filed 2026-02-23 | |
| 2024-03-31 | -$4.22M 10-Q · filed 2025-04-30 | -$4.02M derived: sum of 2 quarters · filed 2026-02-23 | -$4.57M derived: sum of 3 quarters · filed 2026-02-23 | -$5.02M derived: sum of 4 quarters · filed 2026-02-23 | ||
| 2023-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | -$352.00K derived: sum of 2 quarters · filed 2026-02-23 | -$803.00K derived: sum of 3 quarters · filed 2026-02-23 | -$10.53M 10-K · filed 2026-02-23 | -$10.26M 10-K · filed 2024-02-23 | |
| 2023-09-30 | -$552.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | -$1.00M derived: sum of 2 quarters · filed 2024-10-29 | -$10.73M 10-Q · filed 2024-10-29 | -$10.76M derived: sum of 4 quarters · filed 2024-10-29 | ||
| 2023-06-30 | -$451.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-30 | -$10.17M 10-Q · filed 2024-07-30 | -$10.21M derived: sum of 3 quarters · filed 2024-07-30 | -$13.34M derived: sum of 4 quarters · filed 2024-07-30 | ||
| 2023-03-31 | -$9.72M 10-Q · filed 2024-04-29 | -$9.76M derived: sum of 2 quarters · filed 2024-04-29 | -$12.89M derived: sum of 3 quarters · filed 2024-04-29 | -$26.38M derived: sum of 4 quarters · filed 2024-04-29 | ||
| 2022-12-31 | -$36.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | -$3.17M derived: sum of 2 quarters · filed 2024-02-23 | -$16.66M derived: sum of 3 quarters · filed 2024-02-23 | -$5.53M 10-K · filed 2024-02-23 | ||
| 2022-09-30 | -$3.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | -$16.62M derived: sum of 2 quarters · filed 2023-11-03 | -$5.49M 10-Q · filed 2023-11-03 | -$239.00K derived: sum of 4 quarters · filed 2023-11-03 | ||
| 2022-06-30 | -$13.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$2.36M 10-Q · filed 2023-08-08 | $2.90M derived: sum of 3 quarters · filed 2023-08-08 | -$416.00K derived: sum of 4 quarters · filed 2023-08-08 | ||
| 2022-03-31 | $11.13M 10-Q · filed 2023-05-09 | $16.38M derived: sum of 2 quarters · filed 2023-05-09 | $13.07M derived: sum of 3 quarters · filed 2023-05-09 | $4.30M derived: sum of 4 quarters · filed 2023-05-09 | ||
| 2021-12-31 | $5.25M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $1.94M derived: sum of 2 quarters · filed 2023-03-16 | -$6.83M derived: sum of 3 quarters · filed 2023-03-16 | -$5.54M 10-K · filed 2023-03-16 | ||
| 2021-09-30 | -$3.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$12.08M derived: sum of 2 quarters · filed 2022-11-14 | -$10.79M 10-Q · filed 2022-11-14 | -$3.33M derived: sum of 4 quarters · filed 2023-03-16 | ||
| 2021-06-30 | -$8.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$7.48M 10-Q · filed 2022-08-15 | -$24.00K derived: sum of 3 quarters · filed 2023-03-16 | |||
| 2021-03-31 | $1.30M 10-Q · filed 2022-05-12 | $8.75M derived: sum of 2 quarters · filed 2023-03-16 | ||||
| 2020-12-31 | $7.45M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $10.61M 10-K · filed 2023-03-16 | ||||
| 2020-09-30 | $3.16M 10-Q · filed 2021-11-15 | |||||
| 2019-12-31 | $4.57M 10-K · filed 2022-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |